Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Neck moves and posture fixes show promise for migraine relief

NCT ID NCT07403175

Symptom relief Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether combining posture correction exercises with a gentle neck mobilization technique called SNAGs could reduce migraine severity, disability, and improve quality of life. Forty-four adults with episodic migraine participated. The approach is non-drug and focuses on physical therapy, aiming to provide an alternative or add-on to standard migraine treatments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sustained Natural Apophyseal Glides (SNAGs) plus postural correction exercises
What this could lead to
If it works, this could offer a non-drug, hands-on therapy option to ease migraine symptoms and improve daily function.
What could go wrong
This is a small, completed trial with only 44 participants, so results may not apply to everyone. It tested a physical therapy technique, not a cure, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

44 people

The number who actually took part.

Started

Jan 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * A diagnosis of episodic migraine made by the primary investigator according to ICHD-2. * Symptoms must include at least two of the following: Unilateral pain, Pulsating/throbbing pain, Nausea, Vomiting, Photophobia/phonophobia. * Participants should be full time employees or Desktop users. * Participants have a history of at least migraine \>4 days per month. * Participants having history of migraine lasting from 4-72 hours * Age group between 22 and 45 years. * Both gender male and female. * Participants who agree to cut-off any pharmacological treatment during study. * Participants should have an average score between 3-6 on pain intensity scale. Exclusion Criteria: * Participants having active migraine and other headache types e.g. Cluster headache. * Previous neck/head trauma from \>2 years. * Any neck/head surgery \>2 years * Spinal infections/diseases e.g. Tumor, TB spine * Any history of neurological disorders e.g. stroke, abcess, haemorrhage, haematoma * Severe Osteoporosis * Pregnancy * Upper motor neuron disease, cervical stenosis, and metabolic diseases in bone and joint. * Ongoing radiotherapy, chemotherapy, steroid therapy, or anticoagulants. * Psychiatric diseases such as phobia/obsession and depression.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Migraine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Headache migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Migraine

Contacts and locations

Locations

  • Abdul Ahaad Hospital, Sialkot

    Sialkot, Punjab Province, 51413, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.